klh
Showing 1 - 6 of 6
Multiple Sclerosis, Relapsing-Remitting Trial in Canada, United States (23-PPV, 13-PCV Booster, Influenza Vaccine)
Completed
- Multiple Sclerosis, Relapsing-Remitting
- 23-PPV
- +5 more
-
Cullman, Alabama
- +21 more
Apr 4, 2022
Leukemia, Acute Myelogenous (AML), Leukemia, Acute Lymphocytic (ALL), Leukemia, Chronic Myelogenous (CML) Trial run by the NCI
Completed
- Leukemia, Acute Myelogenous (AML)
- +4 more
- WT1 Peptide-Pulsed Dendritic Cells
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 1, 2017
Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma Trial in Worldwide (Rindopepimut (CDX-110) with GM-CSF,
Completed
- Glioblastoma
- +4 more
- Rindopepimut (CDX-110) with GM-CSF
- +2 more
-
Birmingham, Alabama
- +222 more
Jan 11, 2018
Immunoproliferative Disorder Trial run by the NIAID (Bacteriophage, rhuCD40L, KLH)
Completed
- Immunoproliferative Disorder
- Bacteriophage
- +2 more
-
Bethesda, MarylandNational Institute of Allergy and Infectious Diseases (NIAID)
Mar 3, 2008